RxDoctor Payments Data

Gary Tse, MD

Vascular & Interventional Radiology · Los Angeles, CANPI 1043577570

Payments from drug & device makers

What this record shows

22 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 36.8% of the total. Reporting peaked in 2023 at $12,163 and has fallen 60.0% since, to $4,862 in 2025.

$28,763in general payments, 2019–2025

Across 191 payments — averaging $150.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$11K
  • Boston Scientific$6K
  • Penumbra, Inc.$6K
  • Medtronic$1K
  • Stryker$1K
  • Johnson & Johnson$1K
  • plus $3K from 16 others
$100,235in research payments, 2019–2025

Across 2 payments — averaging $50,118 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Blackswan Vascular, Inc.$100K

What the payments were for

  • Travel & lodging$15,96856%
  • Food & beverage$12,79544%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,763 in reported general payments places this provider in the 80th percentile of 504 vascular & interventional radiology providers in California.

See all vascular & interventional radiology providers in California

Medicare billing

Part B allowed, 2024
$129,547
Medicare patients
533
Services billed
916

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →